On September 14th, 2016, The National Council for Behavioral Health (National Council) testified during the Open Public Hearing (OPH) portion of the FDA Joint Meeting of the Psychopharmacologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee.  

The National Council urges the removal of the FDA’s black box warning for varenicline. Please see the attached file for our full testimony.

You May Also Like

Leave a Reply

Your email address will not be published. Required fields are marked *